About: MDA5 is a research topic. Over the lifetime, 740 publications have been published within this topic receiving 80681 citations. The topic is also known as: DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide & MDA-5.
TL;DR: Two fatal cases of fulminant, rapidly progressive interstitial lung disease secondary to MDA5 dermatomyositis presenting with atypical skin manifestations.
Abstract: Abstract Anti-MDA5 dermatomyositis (DM) is a rare systemic autoimmune condition associated with clinically amyopathic DM and rapidly progressive interstitial lung disease (RP-ILD). It is associated with unique skin features including cutaneous ulceration, eyelid oedema, palmar papules and mechanic’s hands. We present two challenging cases of anti-MDA5 DM with atypical skin manifestations, complicated by RP-ILD, which unfortunately resulted in death in both patients. The first case is a 47-year-old Egyptian woman who initially presented with erythema and burning sensation of the fingertips, thigh rash, arthralgia, joint swelling, dry cough and reduced exercise tolerance. She was diagnosed with undifferentiated inflammatory arthritis and possible amyopathic DM and started on methotrexate and systemic steroids. An autoimmune panel showed weakly positive rheumatoid factor but negative antinuclear antibodies, extractable nuclear antigen, dsDNA, antineutrophil cytoplasmic antibodies and anti-Jo1. Subsequently she presented to accident and emergency with worsening breathlessness and productive cough and was admitted to the intensive care unit, treated for pneumonia. A high-resolution computed tomography (CT) scan was reviewed at a tertiary multidisciplinary team, showing an RP-ILD picture, most likely due to MDA5 DM. She was started on pulsed intravenous methylprednisolone and transferred to a tertiary centre for extracorporeal membrane oxygenation (ECMO) and consideration of rituximab. Unfortunately, she died shortly after. She demonstrated positive anti-MDA5 serology. The second case is a 60-year-old Chinese woman who initially presented to ophthalmology with left-eye oedema and was diagnosed with preseptal cellulitis. Subsequently, she presented again to accident and emergency with fatigue, unintentional weight loss, and reduced mobility. She was cachectic with ulcerating skin lesions on her shoulders and hips. Initial CT of the chest–abdomen–pelvis showed patchy consolidation in both lungs, with nodularity and ground-glass changes. She developed pyrexia and mild hypoxia and was treated for bilateral pneumonia. During admission, fasciculations in her upper limbs and tongue prompted a neurology review. Nerve conduction studies demonstrated myopathic changes. Creatine kinase was elevated, and magnetic resonance imaging of the lower limbs confirmed diffuse oedema. Concurrently, she was noted to have mechanic’s hands and Gottron papules. She developed severe type 1 respiratory failure, requiring transfer to intensive care. Repeat CT imaging showed worsening bilateral consolidation and ground-glass changes, with pleural effusions. Her rapidly progressive respiratory failure in the context of likely DM prompted urgent referral to a tertiary centre for ECMO and aggressive immunosuppression. Unfortunately, she died 3 weeks later. Autoantibody testing confirmed positive anti-MDA5 and Ro52 antibodies.
TL;DR: Anti-MDA5 DM is an aggressive phenotype of DM associated with rapidly progressive interstitial lung disease (RP-ILD) and carries high mortality. Early detection is crucial for improved outcomes.
Abstract: Anti-melanoma differentiation-associated gene 5-positive (Anti-MDA5) dermatomyositis (DM) is an aggressive phenotype of DM associated with rapidly progressive interstitial lung disease (RP-ILD). It is a rare condition that carries high mortality. Diagnosis and management of patients with anti-MDA5 DM RP-ILD presents several challenges, including uncertainty around treatment algorithms and a lack of evidence to inform practice. This case report of a patient with anti-MDA5 DM RP-ILD highlights these challenges, emphasising the fulminant course of this disease despite aggressive immunosuppression. Further research is required to guide management and to minimise morbidity and mortality, and greater awareness of the condition is required to minimise delays in diagnosis.
TL;DR: This study elucidates how distinct pattern recognition receptors (RIG-I, MDA5, TLR7) sense Ebinur Lake virus (EBIV) and trigger cell-specific immune responses, dictating innate immunity and pathogenesis through differential sensing of viral RNA and activation of IFN-I and inflammatory responses.
Abstract: Ebinur Lake virus (EBIV) is a recently identified orthobunyavirus with broad host range and zoonotic potential, posing a public health risk. However, the mechanisms underlying EBIV pathogenesis and host innate immune responses remain unclear. Here, we investigated the pattern recognition receptors (PRRs) responsible for sensing EBIV infection and subsequent pathogenesis. EBIV infects diverse cell types and exhibits broad tissue tropism in vivo. In vitro, RIG-I was essential for type I interferon (IFN-I) and inflammatory responses in HEK293 and A549 cells. In contrast, both RIG-I and MDA5 contributed to IFN-I induction in Huh-7 and HCT116 cells, correlating with the specific accumulation of viral dsRNA intermediates in these cell types. Both RIG-I and MDA5 preferentially recognize RNA derived from the viral S segment; however, they have different abilities in sensing incoming viral genomic RNA bearing a 5'-phosphate motif and the replication intermediates. In vivo, RIG-I deficiency severely impairs host defense, while MDA5 deficiency has a more restricted effect in the spleen and liver. In addition to RIG-I and MDA5, TLR7, which is predominantly expressed in dendritic cells, also plays a crucial role for host defense by mediating systemic inflammatory cytokine production without significantly impacting IFN-I response. Our findings suggest that multiple innate sensing receptors, including RIG-I, MDA5, and TLR7, are differentially involved in host defense against EBIV by mediating IFN-I and inflammatory responses, respectively, in a cell-specific manner.IMPORTANCEThis study elucidates the complex mechanisms by which host RIG-I, MDA5, and TLR7 sense the emerging EBIV and trigger cell-specific immune responses. These findings not only clarify crucial aspects of EBIV-host interactions, particularly the differential sensing of viral RNA by distinct PRRs, but also underscore how this differential sensing dictates cell-specific innate immune activation (IFN-I vs. inflammatory responses) and viral pathogenesis, providing critical insights for understanding and combating EBIV and related emerging bunyaviruses.
TL;DR: Recent advances pertinent to the interplay of HSV and the induction of innate immunity mediated by pathogen recognition receptors or pathways are described.